Title
Alpha-1 Antitrypsin Deficiency
Document Type
Presentation
Publication Date
9-21-2011
Abstract
Overall goals and objectives:
1. To understand testing strategies for rare genetic diseases.
2. To understand the pathogenesis of lung and liver disease in Alpha-1 Antitrypsin deficiency.
3. To understand the impact of rare disease communities in the health care system.
Recommended Citation
Strange, Charlie, "Alpha-1 Antitrypsin Deficiency" (2011). Integrative Medicine Lectures, Presentations & Grand Rounds. Presentation 42.
https://jdc.jefferson.edu/jmbcim_lectures/42
COinS
Comments
Dr. Strange is a Professor of Pulmonary, Critical Care, Allergy and Sleep Medicine at MUSC. Dr. Strange's recent honors are as follows: Best Doctors in America 2003-2012: General Pulmonary and Critical Care Medicine, Intestitial Lung Diseases, Chronic Obstructive Pulmonary Disease, America's Top Physicians 2004-2010, Consumers Research Council of America, Who's Who in Medicine and Healthcare 2006-2009, First Runner Up, Medical Jeopardy, AOA Chapter, 1999: Second Runner-Up 2008. MUSC Medical Student Faculty Excellence Award Nominee-2006, Distinguished Service Award 2007-Chest Foundation Community Service Award 2008-Alpha-1 Association. Dr. Strange's Major Interests are Alpha-1 Antitrypsin, Deficiency/Chronic Obstructive Pulmonary Disease, Scleroderma and Intertitial Lung Disease, and Pulmonary Hypertension.
This lecture was delivered as part of the Jefferson-Myrna Brind Center of Integrative Medicine's Grand Rounds series on September 21, 2011. Copyright 2011 by Charlie Strange, MD.
The streaming video presentation lasts approximately 59 minutes.